90 studies found for:    Open Studies | "Hypercholesterolemia"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hypercholesterolemia" (90 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Conditions: Familial Hypercholesterolemia;   Lipid Disorder
Intervention:
2 Recruiting Study of Awareness and Detection of Familial Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
3 Not yet recruiting Open Label Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).
Condition: Familial Hypercholesterolemia
Intervention: Biological: evolocumab (AMG 145)
4 Recruiting French Observatory of Familial Hypercholesterolemia in Cardiology
Condition: Familial Hypercholesterolemia
Intervention:
5 Recruiting Russian Familial Hypercholesterolemia Registry
Condition: Familial Hypercholesterolemia
Intervention:
6 Unknown  Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe;   Drug: Simvastatin + Ezetimibe
7 Unknown  Efficacy Study of Vitamin D and Statins to Treat Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: vitamin D3 tablets;   Drug: placebo tablets
8 Unknown  Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Conditions: Hypertriglyceridaemia;   Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule;   Drug: HMG Coenzyme reductase
9 Unknown  Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: P-OM3;   Drug: Placebo
10 Recruiting MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)
Condition: Familial Hypercholesterolemia - Heterozygous
Intervention:
11 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
12 Unknown  Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
Condition: Heterozigous Familial Hypercholesterolemia
Intervention: Drug: Statins and Ezetimibe
13 Recruiting EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA
Condition: HYPERCHOLESTEROLEMIA
Interventions: Dietary Supplement: CARDICHOL;   Dietary Supplement: PLACEBO
14 Unknown  A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Crestor®
15 Recruiting A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
Condition: Hypercholesterolemia
Interventions: Drug: Ezetimibe 10 mg;   Drug: Atorvastatin 10 mg;   Drug: Placebo for Ezetimibe 10 mg tablet;   Drug: Placebo for Atorvastatin 10 mg capsule;   Behavioral: Diet control/Daily Exercise
16 Recruiting A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: CAT-2054;   Drug: Placebo;   Drug: Atorvastatin
17 Recruiting Atherosclerosis in Familial Hypercholesterolemia
Condition: Familial Hypercholesterolemia
Intervention: Other: CT coronary angiogram and carotid ultrasound
18 Recruiting Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
Condition: Hypercholesterolaemia
Interventions: Drug: alirocumab SAR236553 (REGN727);   Drug: placebo;   Drug: atorvastatin;   Drug: fenofibrate;   Drug: bezafibrate;   Drug: ezetimibe
19 Recruiting Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies
Condition: Hypercholesterolemia
Interventions: Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo (for injection training only)
20 Recruiting Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)
Condition: Hypercholesterolaemia
Interventions: Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo;   Drug: insulin;   Drug: statin;   Drug: lipid modifying therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years